RESONANCE HEALTH
RESONANCE HEALTH operates in Diversified Metals & Mining.
RESONANCE HEALTH (RSN) - Net Assets
Latest net assets as of June 2024: €10.93 Million EUR
Based on the latest financial reports, RESONANCE HEALTH (RSN) has net assets worth €10.93 Million EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€20.28 Million) and total liabilities (€9.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €10.93 Million |
| % of Total Assets | 53.9% |
| Annual Growth Rate | 13.27% |
| 5-Year Change | 10.35% |
| 10-Year Change | N/A |
| Growth Volatility | 25.57 |
RESONANCE HEALTH - Net Assets Trend (2016–2024)
This chart illustrates how RESONANCE HEALTH's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RESONANCE HEALTH (2016–2024)
The table below shows the annual net assets of RESONANCE HEALTH from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | €10.93 Million | +10.03% |
| 2023-06-30 | €9.94 Million | -7.07% |
| 2022-06-30 | €10.69 Million | -9.61% |
| 2021-06-30 | €11.83 Million | +19.40% |
| 2020-06-30 | €9.91 Million | +68.08% |
| 2019-06-30 | €5.89 Million | +42.56% |
| 2018-06-30 | €4.13 Million | +10.70% |
| 2017-06-30 | €3.73 Million | -7.42% |
| 2016-06-30 | €4.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to RESONANCE HEALTH's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 69141800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €76.80 Million | 702.59% |
| Total Equity | €10.93 Million | 100.00% |
RESONANCE HEALTH Competitors by Market Cap
The table below lists competitors of RESONANCE HEALTH ranked by their market capitalization.
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RESONANCE HEALTH's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 9,935,311 to 10,931,634, a change of 996,323 (10.0%).
- Net income of 169,303 contributed positively to equity growth.
- Other factors increased equity by 827,020.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €169.30K | +1.55% |
| Other Changes | €827.02K | +7.57% |
| Total Change | €- | 10.03% |
Book Value vs Market Value Analysis
This analysis compares RESONANCE HEALTH's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.86x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.80x to 4.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €0.01 | €0.12 | x |
| 2018-06-30 | €0.01 | €0.12 | x |
| 2019-06-30 | €0.01 | €0.12 | x |
| 2020-06-30 | €0.02 | €0.12 | x |
| 2021-06-30 | €0.03 | €0.12 | x |
| 2022-06-30 | €0.02 | €0.12 | x |
| 2023-06-30 | €0.02 | €0.12 | x |
| 2024-06-30 | €0.02 | €0.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RESONANCE HEALTH utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.97%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 1.86x
- Recent ROE (1.55%) is above the historical average (-1.10%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -9.53% | -15.09% | 0.52x | 1.22x | €-787.76K |
| 2017 | -8.15% | -12.24% | 0.54x | 1.24x | €-677.69K |
| 2018 | 5.43% | 7.76% | 0.62x | 1.13x | €-188.80K |
| 2019 | 21.55% | 35.05% | 0.56x | 1.09x | €680.88K |
| 2020 | -7.22% | -19.49% | 0.35x | 1.06x | €-1.71 Million |
| 2021 | 4.95% | 15.50% | 0.30x | 1.05x | €-596.88K |
| 2022 | -10.68% | -29.83% | 0.33x | 1.09x | €-2.21 Million |
| 2023 | -7.85% | -17.72% | 0.40x | 1.11x | €-1.77 Million |
| 2024 | 1.55% | 1.97% | 0.42x | 1.86x | €-923.86K |
Industry Comparison
This section compares RESONANCE HEALTH's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RESONANCE HEALTH (RSN) | €10.93 Million | -9.53% | 0.86x | $1.20K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |